Labiotech
Financials
Estimates*
USD | 2020 | 2021 | 2022 |
---|---|---|---|
Revenues | 1.5m | 1.5m | 1.1m |
% growth | - | - | (25 %) |
Profit | <1m | <1m | - |
% profit margin | 4 % | 12 % | - |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Seed | ||
* | N/A | Seed | |
Total Funding | - |
Related Content
Recent News about Labiotech
EditLabiotech.eu is a premier digital media platform dedicated to covering the European biotechnology industry. Founded in 2014 by two biotech engineers, the platform addresses the gap in digital media coverage for the biotech sector in Europe. Labiotech.eu serves a diverse audience, including biotech professionals, researchers, investors, and enthusiasts, with a monthly readership of 150,000 visitors. The platform offers a wide range of content, including news, in-depth articles, reports, podcasts, and expert advice, making it a go-to resource for the latest developments in biotechnology.
The business operates in the digital media market, specifically targeting the biotech industry. Its business model revolves around content creation and distribution, generating revenue through advertising, sponsored content, and subscriptions. By providing high-quality, up-to-date information, Labiotech.eu attracts a loyal readership and valuable advertising partners.
Labiotech.eu's mission is to establish itself as the leading biotech media in Europe, continually investing in content, product launches, and team expansion. The platform also engages with its audience through surveys and reader tips, ensuring a dynamic and interactive user experience.
Keywords: biotech media, European biotechnology, digital platform, biotech news, industry insights, content creation, advertising revenue, sponsored content, biotech professionals, research updates.